745 related articles for article (PubMed ID: 29633510)
1. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
Xue D; Lu H; Xu HY; Zhou CX; He XZ
J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
Bai T; Liu Y; Li B
IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
[TBL] [Abstract][Full Text] [Related]
3. Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway.
Tan X; Song X; Fan B; Li M; Zhang A; Pei L
Anticancer Drugs; 2022 Oct; 33(9):871-882. PubMed ID: 36136987
[TBL] [Abstract][Full Text] [Related]
4. MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression.
Wu C; Miao C; Tang Q; Zhou X; Xi P; Chang P; Hua L; Ni H
J Cell Mol Med; 2020 Feb; 24(3):2098-2108. PubMed ID: 31876385
[TBL] [Abstract][Full Text] [Related]
5. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
6. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
Zhang W; Song C; Ren X
Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer.
Zhang W; Xin J; Lai J; Zhang W
Immunobiology; 2022 Jan; 227(1):152163. PubMed ID: 34896914
[TBL] [Abstract][Full Text] [Related]
8. Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p/TrkB axis.
Xing Z; Li S; Xing J; Yu G; Wang G; Liu Z
Lab Invest; 2022 Jun; 102(6):602-612. PubMed ID: 35152275
[TBL] [Abstract][Full Text] [Related]
9. LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p.
Jiang X; Guo S; Zhang Y; Zhao Y; Li X; Jia Y; Xu Y; Ma B
Cell Signal; 2020 Jan; 65():109422. PubMed ID: 31672604
[TBL] [Abstract][Full Text] [Related]
10. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
[TBL] [Abstract][Full Text] [Related]
11. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.
Zhang H; Li M; Zhang J; Shen Y; Gui Q
Drug Des Devel Ther; 2021; 15():1835-1849. PubMed ID: 33976535
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1.
Zhang G; He X; Ren C; Lin J; Wang Q
J Cell Physiol; 2019 Aug; 234(8):13097-13109. PubMed ID: 30569456
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis.
Wu M; Huang Y; Chen T; Wang W; Yang S; Ye Z; Xi X
J Cell Mol Med; 2019 Jan; 23(1):29-38. PubMed ID: 30565858
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axis.
Wang D; Zhang S; Zhao M; Chen F
Cancer Med; 2020 Dec; 9(23):9138-9149. PubMed ID: 33146951
[TBL] [Abstract][Full Text] [Related]
15. LncRNA AFAP1-AS1 modulates the sensitivity of paclitaxel-resistant prostate cancer cells to paclitaxel via miR-195-5p/FKBP1A axis.
Leng W; Liu Q; Zhang S; Sun D; Guo Y
Cancer Biol Ther; 2020 Nov; 21(11):1072-1080. PubMed ID: 33138677
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis.
Cao Y; Zhang F; Wang H; Bi C; Cui J; Liu F; Pan H
Mol Cell Biochem; 2021 Jan; 476(1):279-292. PubMed ID: 32965597
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA OGFRP1/miR-149-5p/IL-6 axis regulates prostate cancer chemoresistance.
Wang C; Ding T; Yang D; Zhang P; Hu X; Qin W; Zheng J
Pathol Res Pract; 2021 Aug; 224():153535. PubMed ID: 34293716
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
Li X; Han X; Wei P; Yang J; Sun J
Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
[TBL] [Abstract][Full Text] [Related]
19. [LncRNA RPL22P1-201 affects prostate cancer cell proliferation, cell cycle, and sensitivity to docetaxel by regulating miR-216b-5p expression].
Yang C; Xue JG
Zhonghua Nan Ke Xue; 2023 Oct; 29(10):881-887. PubMed ID: 38639656
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
Song X; Wang H; Wu J; Sun Y
Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
[No Abstract] [Full Text] [Related]
[Next] [New Search]
